Evaluation of the Efficacy and Tolerability of Bedaquiline in Drug-Resistant Tuberculosis

Hitesha H Trivedi, Suraj Tripathi, Parth Patel, Mittal C Balat, Mohmed Sohel Shaikh, Nilesh Patil · 2026

Read Evaluation of the Efficacy and Tolerability of Bedaquiline in Drug-Resistant Tuberculosis by Hitesha H Trivedi, Suraj Tripathi, Parth Patel, Mittal C Balat, Mohmed Sohel Shaikh, Nilesh Patil (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13630714.txt.

Description

Hitesha H Trivedi and five co-authors judge a key drug for drug-resistant tuberculosis. Their 2026 study follows patients on bedaquiline-based treatment in India. Resistant tuberculosis leaves few working drug options. Bedaquiline anchors modern regimens, so its real-world record matters.

Sixty-four patients at one hospital clinic were followed month by month from 2024 into 2025. Sputum tests turned negative in about ninety-five percent of them. All carried germs resistant to rifampicin, the classic first drug. Most isolates still answered to injectable drugs. The team tracked side effects, lab values, and pill-taking faithfully. Conversion did not hinge on age or other traits. The drug held up well in routine care.

Catalog record

CREATORHitesha H Trivedi, Suraj Tripathi, Parth Patel, Mittal C Balat, Mohmed Sohel Shaikh, Nilesh Patil
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13630714

Browse the full library · About the Tower of Babel